Login Get in touch
Food Safety Incidents

Inaccurate Labeling has been detected in Opioid drug products.

June 30 2025

Explore Regulations & Risks

On June 24, 2025, the U.S. Food and Drug Administration reported an incident involving inaccurate labeling detected in opioid drug products. This issue was categorized under "Other incidents" and falls within the hazard category of...

Articles in this database are automatically generated by our AI system based on data from the Digicomply APP. While we strive for accuracy, the articles may not contain complete or verified information and are intended for informational purposes only. For accurate and reliable information, we recommend using SGS Digicomply or consulting verified sources and experts. All content is copyrighted; please credit SGS Digicomply (digicomply.com) when sharing.

On June 24, 2025, the U.S. Food and Drug Administration reported an incident involving inaccurate labeling detected in opioid drug products. This issue was categorized under "Other incidents" and falls within the hazard category of labeling.

The incident originated in the United States of America and raises concerns regarding the accuracy of information provided on the labels of these products. Inaccurate labeling can lead to potential risks for consumers and healthcare providers, affecting dosage instructions and usage guidelines.

The U.S. Food and Drug Administration is responsible for monitoring the safety and efficacy of pharmaceutical products, including opioids. The agency's identification of this labeling issue highlights the importance of accurate product information in ensuring public safety and maintaining trust in medication distribution.

As the situation develops, further information may be provided by regulatory authorities to address the implications of the inaccurate labeling and to implement corrective measures. Stakeholders in the healthcare and pharmaceutical sectors are advised to remain vigilant regarding updates and necessary actions related to this incident.


  • Incident: Inaccurate Labeling has been detected in Opioid drug products.
  • Date: 2025-06-24
  • Product: Opioid drug products
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: United States of America
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Other incident
  • Hazard Category: Labelling
  • Source: U.S. Food and Drug Administration

For more detailed information about this and other similar incidents, with access to filtering options, historical data, and trend analysis, try the SGS Digicomply Food Safety Software. Explore SGS Digicomply Food Safety Intelligence Hub demos here. (for enterprises only, no individual plans)

Tags: June 2025